These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

333 related articles for article (PubMed ID: 18403670)

  • 1. Exercise-induced pulmonary arterial hypertension in patients with systemic sclerosis.
    Steen V; Chou M; Shanmugam V; Mathias M; Kuru T; Morrissey R
    Chest; 2008 Jul; 134(1):146-51. PubMed ID: 18403670
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Usefulness of echocardiography in the identification of an excessive increase in pulmonary arterial pressure in patients with systemic sclerosis.
    Ciurzyński M; Bienias P; Irzyk K; Rymarczyk Z; Kostrubiec M; Szewczyk A; Glińska-Wielochowska M; Zyłkowska J; Kurzyna M; Pruszczyk P
    Kardiol Pol; 2011; 69(1):9-15. PubMed ID: 21267956
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevalence of exercise pulmonary arterial hypertension in scleroderma.
    Callejas-Rubio JL; Moreno-Escobar E; de la Fuente PM; Pérez LL; Fernández RR; Sánchez-Cano D; Mora JP; Ortego-Centeno N
    J Rheumatol; 2008 Sep; 35(9):1812-6. PubMed ID: 18634147
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pulmonary arterial hypertension and severe pulmonary fibrosis in systemic sclerosis patients with a nucleolar antibody.
    Steen VD; Lucas M; Fertig N; Medsger TA
    J Rheumatol; 2007 Nov; 34(11):2230-5. PubMed ID: 17937469
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development of pulmonary hypertension in a high-risk population with systemic sclerosis in the Pulmonary Hypertension Assessment and Recognition of Outcomes in Scleroderma (PHAROS) cohort study.
    Hsu VM; Chung L; Hummers LK; Wigley F; Simms R; Bolster M; Silver R; Fischer A; Hinchcliff ME; Varga J; Goldberg AZ; Derk CT; Schiopu E; Khanna D; Shapiro LS; Domsic RT; Medsger T; Mayes MD; Furst D; Csuka ME; Molitor JA; Alkassab F; Steen VD
    Semin Arthritis Rheum; 2014 Aug; 44(1):55-62. PubMed ID: 24709277
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Right ventricular systolic pressure assessed by echocardiography: a predictive factor of mortality in patients with scleroderma.
    Kiatchoosakun S; Wongvipaporn C; Nanagara R; Hoit BD
    Clin Cardiol; 2011 Aug; 34(8):488-93. PubMed ID: 21717471
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High N-terminal pro-brain natriuretic peptide levels and low diffusing capacity for carbon monoxide as independent predictors of the occurrence of precapillary pulmonary arterial hypertension in patients with systemic sclerosis.
    Allanore Y; Borderie D; Avouac J; Zerkak D; Meune C; Hachulla E; Mouthon L; Guillevin L; Meyer O; Ekindjian OG; Weber S; Kahan A
    Arthritis Rheum; 2008 Jan; 58(1):284-91. PubMed ID: 18163505
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Can we predict the severity of pulmonary hypertension in patients with scleroderma?
    Acosta Colmán MI; Avila Pedretti G; Acosta ME; Simeón Aznar CP; Fonollosa Plá V; Villardel Torrés M
    Reumatol Clin; 2012; 8(5):259-62. PubMed ID: 22658662
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pericardial abnormalities predict the presence of echocardiographically defined pulmonary arterial hypertension in systemic sclerosis-related interstitial lung disease.
    Fischer A; Misumi S; Curran-Everett D; Meehan RT; Ulrich SK; Swigris JJ; Frankel SK; Cosgrove GP; Lynch DA; Brown KK
    Chest; 2007 Apr; 131(4):988-92. PubMed ID: 17426200
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Does reduced lung diffusing capacity for carbon monoxide predict the presence of pulmonary hypertension?
    Delcour KS; Singla A; Jarbou M; Alpert M; Dabbagh O
    Am J Med Sci; 2010 Jul; 340(1):54-9. PubMed ID: 20463574
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Echocardiography may help detect pulmonary vasculopathy in the early stages of pulmonary artery hypertension associated with systemic sclerosis.
    Serra W; Chetta A; Santilli D; Mozzani F; Dall'Aglio PP; Olivieri D; Cattabiani MA; Ardissino D; Gherli T
    Cardiovasc Ultrasound; 2010 Jul; 8():25. PubMed ID: 20598164
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Noninvasive detection of early pulmonary vascular dysfunction in scleroderma.
    Reichenberger F; Voswinckel R; Schulz R; Mensch O; Ghofrani HA; Olschewski H; Seeger W
    Respir Med; 2009 Nov; 103(11):1713-8. PubMed ID: 19497725
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Echocardiography and pulmonary function as screening tests for pulmonary arterial hypertension in systemic sclerosis.
    Mukerjee D; St George D; Knight C; Davar J; Wells AU; Du Bois RM; Black CM; Coghlan JG
    Rheumatology (Oxford); 2004 Apr; 43(4):461-6. PubMed ID: 15024134
    [TBL] [Abstract][Full Text] [Related]  

  • 14. D-dimer and pulmonary arterial hypertension in systemic sclerosis.
    Kiatchoosakun S; Ungkasekvinai W; Wonvipaporn C; Tatsanavivat P; Foocharoen C; Suwannaroj S; Nanagara R
    J Med Assoc Thai; 2007 Oct; 90(10):2024-9. PubMed ID: 18041419
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pulmonary Hypertension Assessment and Recognition of Outcomes in Scleroderma (PHAROS): baseline characteristics and description of study population.
    Hinchcliff M; Fischer A; Schiopu E; Steen VD;
    J Rheumatol; 2011 Oct; 38(10):2172-9. PubMed ID: 21844142
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Impact of bosentan therapy on stress-induced pulmonary hypertension in patients with systemic sclerosis].
    Volkov AV; Kurmukov IA; Yudkina NN; Glukhova SI; Nikolaeva EV
    Ter Arkh; 2015; 87(1):49-56. PubMed ID: 25823269
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Echo Doppler predictors of pulmonary artery hypertension in patients with systemic sclerosis.
    Frea S; Capriolo M; Marra WG; Cannillo M; Fusaro E; Libertucci D; Morello M; Gaita F
    Echocardiography; 2011 Sep; 28(8):860-9. PubMed ID: 21906161
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical characteristics and survival in systemic sclerosis-related pulmonary hypertension associated with interstitial lung disease.
    Launay D; Humbert M; Berezne A; Cottin V; Allanore Y; Couderc LJ; Bletry O; Yaici A; Hatron PY; Mouthon L; Le Pavec J; Clerson P; Hachulla E
    Chest; 2011 Oct; 140(4):1016-1024. PubMed ID: 21474572
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A study on pulmonary complications of systemic sclerosis in eastern India.
    Ghosh A; Banerjee A; Biswas AK
    Indian J Chest Dis Allied Sci; 2014; 56(4):231-5. PubMed ID: 25962196
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical and echocardiographic correlations of exercise-induced pulmonary hypertension in systemic sclerosis: a multicenter study.
    Gargani L; Pignone A; Agoston G; Moreo A; Capati E; Badano LP; Doveri M; Bazzichi L; Costantino MF; Pavellini A; Pieri F; Musca F; Muraru D; Epis O; Bruschi E; De Chiara B; Perfetto F; Mori F; Parodi O; Sicari R; Bombardieri S; Varga A; Cerinic MM; Bossone E; Picano E
    Am Heart J; 2013 Feb; 165(2):200-7. PubMed ID: 23351823
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.